These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17942010)

  • 1. Course of cognitive decline in Parkinson's disease: a meta-analysis.
    Muslimović D; Schmand B; Speelman JD; de Haan RJ
    J Int Neuropsychol Soc; 2007 Nov; 13(6):920-32. PubMed ID: 17942010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.
    Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ
    Neuropsychology; 2005 Jul; 19(4):520-31. PubMed ID: 16060827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive decline in early Parkinson's disease.
    Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
    Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
    Athey RJ; Walker RW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.
    Caviness JN; Hentz JG; Evidente VG; Driver-Dunckley E; Samanta J; Mahant P; Connor DJ; Sabbagh MN; Shill HA; Adler CH
    Parkinsonism Relat Disord; 2007 Aug; 13(6):348-54. PubMed ID: 17347022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study.
    Broeders M; Velseboer DC; de Bie R; Speelman JD; Muslimovic D; Post B; de Haan R; Schmand B
    J Int Neuropsychol Soc; 2013 Jul; 19(6):695-708. PubMed ID: 23544964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Education and cognitive decline in Parkinson's disease: a study of 102 patients.
    Pai MC; Chan SH
    Acta Neurol Scand; 2001 Apr; 103(4):243-7. PubMed ID: 11328196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.
    Shadlen MF; Larson EB; Wang L; Phelan EA; McCormick WC; Jolley L; Teri L; van Belle G
    Neurobiol Aging; 2005 Jan; 26(1):17-24. PubMed ID: 15585342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring cognitive function with age: the influence of selection by health and survival.
    Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM
    Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1043-9. PubMed ID: 14618557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
    Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between clinical characteristics of Parkinson's disease and cognitive decline.
    Locascio JJ; Corkin S; Growdon JH
    J Clin Exp Neuropsychol; 2003 Feb; 25(1):94-109. PubMed ID: 12607175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.